Gene · 8754
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular mechanisms underlying the impairment of macrophage efferocytosis. | Immunol Lett | 2023 | 36740099 | PubTator, text mining | PubMed |
| The dual role of microRNA (miR)-20b in cancers: Friend or foe? | Cell Commun Signal | 2023 | 36717861 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
| Early peripheral blood gene expression associated with good and poor 90-day ischemic stroke outcomes. | J Neuroinflammation | 2023 | 36691064 | PubTator, text mining | PubMed |
| Towards precision medicine: Omics approach for COVID-19. | Biosaf Health | 2023 | 36687209 | PubTator, text mining | PubMed |
| O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation. | Mol Cell Proteomics | 2023 | 36669592 | PubTator, text mining | PubMed |
| Altered host protease determinants for SARS-CoV-2 Omicron. | Sci Adv | 2023 | 36662861 | PubTator, text mining | PubMed |
| Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment. | Int J Oncol | 2023 | 36660950 | PubTator, text mining | PubMed |
| Basal cell adhesion molecule promotes metastasis-associated processes in ovarian cancer. | Clin Transl Med | 2023 | 36647260 | PubTator, text mining | PubMed |
Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling. | Neoplasia | 2023 | 36610378 | PubTator, text mining | PubMed |
| Retraction Notice to: Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3. | Mol Ther Nucleic Acids | 2023 | 36589711 | PubTator, text mining | PubMed |
| PCLassoLog: A protein complex-based, group Lasso-logistic model for cancer classification and risk protein complex discovery. | Comput Struct Biotechnol J | 2023 | 36582441 | PubTator, text mining | PubMed |
| The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. | Oncogene | 2023 | 36572816 | PubTator, text mining | PubMed |
| ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer. | Oncoimmunology | 2023 | 36545255 | PubTator, text mining | PubMed |
| Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expression. | Immunogenetics | 2023 | 36515717 | PubTator, text mining | PubMed |
| Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer. | Oncol Lett | 2023 | 36478910 | PubTator, text mining | PubMed |
| ADAM9: A regulator between HCMV infection and function of smooth muscle cells. | J Med Virol | 2023 | 36437481 | PubTator, text mining | PubMed |
| Circular RNAs: New layer of complexity evading breast cancer heterogeneity. | Noncoding RNA Res | 2023 | 36380816 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Knockdown of circ-ADAM9 inhibits malignant phenotype and enhances radiosensitivity in breast cancer cells via acting as a sponge for miR-383-5p. | Strahlenther Onkol | 2023 | 36205752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8754/papers?page=13